172 related articles for article (PubMed ID: 21646287)
1. Liver iron overload is associated with elevated SHBG concentration and moderate hypogonadotrophic hypogonadism in dysmetabolic men without genetic haemochromatosis.
Gautier A; Lainé F; Massart C; Sandret L; Piguel X; Brissot P; Balkau B; Deugnier Y; Bonnet F
Eur J Endocrinol; 2011 Aug; 165(2):339-43. PubMed ID: 21646287
[TBL] [Abstract][Full Text] [Related]
2. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
[TBL] [Abstract][Full Text] [Related]
3. [Genetic iron overloads and hepatic insulin-resistance iron overload syndrome: an update].
Ruivard M
Rev Med Interne; 2009 Jan; 30(1):35-42. PubMed ID: 18584923
[TBL] [Abstract][Full Text] [Related]
4. Long-term course after initial iron removal of iron excess in patients with dysmetabolic iron overload syndrome.
Bardou-Jacquet E; Lainé F; Morcet J; Perrin M; Guyader D; Deugnier Y
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):418-21. PubMed ID: 24557330
[TBL] [Abstract][Full Text] [Related]
5. Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study.
Chubb SA; Hyde Z; Almeida OP; Flicker L; Norman PE; Jamrozik K; Hankey GJ; Yeap BB
Eur J Endocrinol; 2008 Jun; 158(6):785-92. PubMed ID: 18505902
[TBL] [Abstract][Full Text] [Related]
6. Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial.
Kowdley KV; Modi NB; Peltekian K; Vierling JM; Ferris C; Valone FH; Gupta S
Lancet Gastroenterol Hepatol; 2023 Dec; 8(12):1118-1128. PubMed ID: 37863080
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of iron overload management in allogeneic hematopoietic cell transplantation survivors.
Majhail NS; Lazarus HM; Burns LJ
Biol Blood Marrow Transplant; 2010 Jun; 16(6):832-7. PubMed ID: 20079863
[TBL] [Abstract][Full Text] [Related]
8. Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients.
Lainé F; Ruivard M; Loustaud-Ratti V; Bonnet F; Calès P; Bardou-Jacquet E; Sacher-Huvelin S; Causse X; Beusnel C; Renault A; Bellissant E; Deugnier Y;
Hepatology; 2017 Feb; 65(2):465-474. PubMed ID: 27685251
[TBL] [Abstract][Full Text] [Related]
9. Generalized pruritus in dysmetabolic hyperferritinemia treated by phlebotomy.
Brigant F; Hautefeuille V; Dadban A; Lok C; Nguyen-Khac E; Chaby G
Dermatol Online J; 2015 Sep; 21(9):. PubMed ID: 26437295
[TBL] [Abstract][Full Text] [Related]
10. Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis.
Hicken BL; Tucker DC; Barton JC
Am J Gastroenterol; 2003 Sep; 98(9):2072-7. PubMed ID: 14499790
[TBL] [Abstract][Full Text] [Related]
11. Low sex hormone-binding globulin and testosterone levels in association with erectile dysfunction among human immunodeficiency virus-infected men receiving testosterone and oxandrolone.
Wasserman P; Segal-Maurer S; Rubin D
J Sex Med; 2008 Jan; 5(1):241-7. PubMed ID: 17961146
[TBL] [Abstract][Full Text] [Related]
12. [Correction of insulin resistance syndrome does not cause normalisation of hyperferritinaemia].
Roblin X; Phelip JM; Hilleret MN; Heluwaert F; Bonaz B; Zarski JP
Gastroenterol Clin Biol; 2003 Dec; 27(12):1079-83. PubMed ID: 14770107
[TBL] [Abstract][Full Text] [Related]
13. Reversibility of hypogonadotrophic hypogonadism associated with genetic haemochromatosis.
Cundy T; Butler J; Bomford A; Williams R
Clin Endocrinol (Oxf); 1993 Jun; 38(6):617-20. PubMed ID: 8334747
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the hypothalamic-pituitary-gonadal axis in eugonadal men with type 2 diabetes mellitus.
Costanzo PR; Suárez SM; Scaglia HE; Zylbersztein C; Litwak LE; Knoblovits P
Andrology; 2014 Jan; 2(1):117-24. PubMed ID: 24282162
[TBL] [Abstract][Full Text] [Related]
15. Testosterone and gonadotropin levels in men with dementia.
Hogervorst E; Combrinck M; Smith AD
Neuro Endocrinol Lett; 2003; 24(3-4):203-8. PubMed ID: 14523358
[TBL] [Abstract][Full Text] [Related]
16. LH and non-SHBG testosterone and estradiol levels during testosterone replacement of hypogonadal men: further evidence that steroid negative feedback increases as men grow older.
Winters SJ; Wang C;
J Androl; 2010; 31(3):281-7. PubMed ID: 19959827
[TBL] [Abstract][Full Text] [Related]
17. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy.
Lanfranco F; Zitzmann M; Simoni M; Nieschlag E
Clin Endocrinol (Oxf); 2004 Apr; 60(4):500-7. PubMed ID: 15049966
[TBL] [Abstract][Full Text] [Related]
18. HJV hemochromatosis, iron overload, and hypogonadism in a Brazilian man: treatment with phlebotomy and deferasirox.
Santos PC; Cançado RD; Pereira AC; Chiattone CS; Krieger JE; Guerra-Shinohara EM
Acta Haematol; 2010; 124(4):204-5. PubMed ID: 21071928
[No Abstract] [Full Text] [Related]
19. Effects of phlebotomy therapy on cytochrome P450 2e1 activity and oxidative stress markers in dysmetabolic iron overload syndrome: a randomized trial.
Lainé F; Reymann JM; Morel F; Langouët S; Perrin M; Guillygomarc'h A; Brissot P; Turmel V; Mouchel C; Pape D; Bellissant E; Deugnier Y
Aliment Pharmacol Ther; 2006 Oct; 24(8):1207-13. PubMed ID: 17014579
[TBL] [Abstract][Full Text] [Related]
20. Both total testosterone and sex hormone-binding globulin are independent risk factors for metabolic syndrome: results from Fangchenggang Area Male Health and Examination Survey in China.
Zhang J; Huang X; Liao M; Gao Y; Tan A; Yang X; Zhang H; Mo L; Zhang Y; Lu Z; Wu C; Hu Y; Mo Z
Diabetes Metab Res Rev; 2013 Jul; 29(5):391-7. PubMed ID: 23463406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
